We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$331B
AUM Growth
+$5.64B
Cap. Flow
-$2.7B
Cap. Flow %
-0.81%
Top 10 Hldgs %
12.38%
Holding
6,874
New
204
Increased
2,959
Reduced
3,018
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 9.92%
2 Financials 9.63%
3 Healthcare 8.27%
4 Consumer Discretionary 7.53%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMN icon
6201
ProShares UltraShort Materials
SMN
$4.17M
$3K ﹤0.01%
10
-5
-33% -$1.46K
SVRA icon
6202
Savara
SVRA
$1.12B
$3K ﹤0.01%
+478
New +$3.28K
UUU icon
6203
Universal Safety Products Inc
UUU
$11M
$3K ﹤0.01%
900
ZYME icon
6204
Zymeworks
ZYME
$1.61B
$3K ﹤0.01%
+300
New +$3.36K
ENG
6205
DELISTED
ENGlobal Corp
ENG
$3K ﹤0.01%
270
-287
-52% -$3.23K
NBSE
6206
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3K ﹤0.01%
12
+3
+33% +$806
FRTX
6207
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3K ﹤0.01%
+3
New +$2.19K
OIL
6208
DELISTED
iPath Pure Beta Crude Oil ETN
OIL
$3K ﹤0.01%
193
+22
+13% +$320
PLXP
6209
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$3K ﹤0.01%
546
+73
+15% +$534
XELA
6210
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
NBRV
6211
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$3K ﹤0.01%
1
-13
-93% -$33.5K
GSB
6212
DELISTED
GlobalSCAPE, Inc.
GSB
$3K ﹤0.01%
533
-1,015
-66% -$4.47K
OTTW
6213
DELISTED
Ottawa Bancorp, Inc. Common Stock
OTTW
$3K ﹤0.01%
250
+84
+51% +$1.14K
BORN
6214
DELISTED
China New Borun Corporation
BORN
$3K ﹤0.01%
2,100
+1,600
+320% +$1.99K
ADYX
6215
DELISTED
Adynxx Inc
ADYX
$3K ﹤0.01%
113
+91
+414% +$2.14K
CFCOU
6216
DELISTED
CF Corporation
CFCOU
$3K ﹤0.01%
300
SPI
6217
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$3K ﹤0.01%
34
+32
+1,600% +$2.68K
WCST
6218
DELISTED
Wecast Network, Inc. Common Stock
WCST
$3K ﹤0.01%
+1,425
New +$3.67K
TEAR
6219
DELISTED
TearLab Corporation
TEAR
$3K ﹤0.01%
1,701
RELY
6220
DELISTED
Real Industry, Inc.
RELY
$3K ﹤0.01%
1,085
-36,349
-97% -$99.1K
CELGZ
6221
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$3K ﹤0.01%
2,364
+1,125
+91% +$1.29K
WBIH
6222
DELISTED
WBI BullBear Global High Income ETF
WBIH
$3K ﹤0.01%
+123
New +$3.01K
NMRX
6223
DELISTED
Numerex Corp
NMRX
$3K ﹤0.01%
668
-17,623
-96% -$78.5K
PTM
6224
DELISTED
E-TRACS UBS Long Platinum ETN
PTM
$3K ﹤0.01%
352
ACHV icon
6225
Achieve Life Sciences
ACHV
$659M
$2K ﹤0.01%
2

Similar funds

Morgan Stanley's Q2 2017 Portfolio in Review

As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

  • Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
  • Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
  • Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
  • Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
  • Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
  • Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
  • Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.

Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.